Skip to main content

Advertisement

Log in

Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement

  • Oculoplastics and Orbit
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

The purpose was to ascertain if any relation exists between the elevated intraocular pressure (IOP) in patients with thyroid-associated orbitopathy (TAO) in active stage and the severity of extraocular muscle involvement and the extent of exophthalmos.

Methods

A total of 96 eyes and orbits of 48 adult patients with active TAO were investigated. All patients underwent magnetic resonance imaging of the orbit and measurement of all extraocular recti muscles (EOM). The obtained data was divided into two groups according to the IOP value: normal IOP ≤ 21 mmHg; n = 47 and elevated IOP with IOP > 21 mmHg; n = 49, and analyszed.

Results

A significant difference was found in the short diameter of medial rectus and inferior rectus muscles and in the sum of short parameters of all EOM. All these parameters were significantly higher in the elevated IOP group. Motility restriction in at least one gaze direction was also significantly more frequent (p < 0.0001) in the elevated IOP group. A positive moderate correlation was found between IOP and the sum of short parameters of EOM (r = 0.496). No correlation was found between the IOP and exophthalmos values (r = 0.267). During the follow-up, the frequency of strabismus surgery and orbital decompression was significantly higher in the elevated IOP group (p = 0.003; p = 0.002).

Conclusion

Elevated IOP in the active TAO stage particularly correlates with extraocular muscle involvement. These patients are also more likely to require orbital decompression and strabismus surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wessely K (1918) Discussion of Hertel E. Der Dtsch Ophthlmol Ges 41:80–81

    Google Scholar 

  2. Ohtsuka K, Nakamura Y (2000) Open-angle glaucoma associated with Graves disease. Am J Ophthalmol 129(5):613–617

    Article  PubMed  CAS  Google Scholar 

  3. Behrouzi Z, Rabei HM, Azizi F, Daftarian N, Mehrabi Y, Ardeshiri M, Mohammadpour M (2007) Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J Glaucoma 16(4):358–362

    Article  PubMed  Google Scholar 

  4. Cockerham KP, Pal C, Jani B, Wolter A, Kennerdell JS (1997) The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Ophthalmology 104(6):914–917

    Article  PubMed  CAS  Google Scholar 

  5. Kalmann R, Mourits MP (1998) Prevalence and management of elevated intraocular pressure in patients with Graves’ orbitopathy. Br J Ophthalmol 82:754–757

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Da Silva FLM, de Lourdes Veronese Rodrigues M, Akaishi PMS, Cruz AAV (2009) Graves’ orbitopathy: frequency of ocular hypertension and glaucoma. Eye 23(4):957–959

    Article  PubMed  Google Scholar 

  7. Konuk O, Onaran Z, Ozhan Oktar S, Yucel C, Unal M (2009) Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves’ orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol 247(11):1555–1559

    Article  PubMed  Google Scholar 

  8. Mouritz MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves´ ophthalmopathy: a novel approach. Br J Ophthalmol 73:639–644

    Article  Google Scholar 

  9. Åsman P (2003) Ophthalmological evaluation in thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 81:437–448

    Article  PubMed  Google Scholar 

  10. Werner SC (1977) Modification of the classification of the eye changes of Graves´ disease: recommendations of the Ad Hoc Commitee of the American Thyroid Association. J Clin Endocrinol Metab 44:203–204

    Article  PubMed  CAS  Google Scholar 

  11. Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, European Group on Graves’ orbitopathy (EUGOGO) (2016) The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the management of Graves’ orbitopathy. Eur Thyroid J 5(1):9–26

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Wiersinga WM, Kahaly GJ (eds) (2010) Graves’ orbitopathy: a multidisciplinary approach-questions and answers, 2nd revised. Karger, Basel, pp 33–39

    Google Scholar 

  13. Fan SX, Zeng P, Li ZJ, Wang J, Liang JQ, Liao YR, Hu YX, Xu MT, Wang M (2021) The clinical features of Graves’ orbitopathy with elevated intraocular pressure. J Ophthalmol 2021:9879503. https://doi.org/10.1155/2021/9879503

    Article  PubMed  PubMed Central  Google Scholar 

  14. Nassr MA, Morris CL, Netland PA, Karcioglu ZA (2009) Intraocular pressure change in orbital disease. Surv Ophthalmol 54(5):519–544

    Article  PubMed  Google Scholar 

  15. Gumińska M, Goś R, Śmigielski J, Nowak MS (2020) Topical treatment of elevated intraocular pressure in patients with Grave’s orbitopathy. Int J Environ Res Public Health 17:9331

    Article  PubMed Central  Google Scholar 

  16. Gharib S, Moazezi Z, Bayani MA (2018) Prevalence and severity of ocular involvement in Graves’ disease according to sex and age: a clinical study from Babol, Iran. Caspian J Intern Med 9(2):178–183

    PubMed  PubMed Central  Google Scholar 

  17. Kuebler AG, Wiecha C, Reznicek L, Klingenstein A, Halfter K, Priglinger S, Hintschich, (2019) Comparison of different devices to measure the intraocular pressure in thyroid-associated orbitopathy. Graefes Arch Clin Exp Ophthalmol 257:2025–2032

    Article  PubMed  Google Scholar 

  18. Stoyanova NS, Konareva-Kostianeva M, Mitkova-Hristova V, Anglova I (2019) Correlation between intraocular pressure and thickness of extraocular muscles, the severity and activity of thyroid-associated orbitopathy. Folia Med (Plovdiv) 61(1):90–96

    Article  CAS  Google Scholar 

  19. Wilinsky RA, Arenson AM, Hurwitz JJ, Szalai J (1984) Ultrasonic B-scan measurement of the extraocular muscles in Graves’ orbitopathy. J Can Assoc Radiol 35:171–173

    Google Scholar 

  20. Fledelius C, Zimmermann-Bielsing T, Feldt-Rasmussen U (2003) Ultrasonically measured horizontal eye muscle thickness in thyroid associated orbitopathy: cross-sectional and longitudinal aspects in a Danish series. Acta Oftalmol Scand 81:143–150

    Article  Google Scholar 

  21. Imbrasienė D, Jankauskienė J, Stanislovaitienė D (2010) Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves’ ophthalmopathy. Medicina (Kaunas) 46:472–476

    Article  Google Scholar 

  22. Karhanova M, Kovar R, Frysak Z, Sin M, Zapletalova J, Rehak J, Herman M (2015) Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 159(2):307–312

    Article  PubMed  Google Scholar 

  23. Spierer A, Eisenstein Z (1991) The role of increased intraocular pressure on upgaze in the assessment of Graves Ophthalmopathy. Ophthalmology 98:1491–1494

    Article  PubMed  CAS  Google Scholar 

  24. Lennerstrand G, Tiam S, Isberg B, Landau Högbeck I, Bolzani R, Tallstedt L, Schworm (2007) Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. Acta Ophthalmol Scand 85:192–201

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Ministry of Health of the Czech Republic–grant no. NU21J-01–00017 and DRO (FNOL, 00098892). All rights reserved.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marta Karhanová.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of the University Hospital Olomouc and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

All authors declare that they have no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article received support from the mentorship team. Further information can be found in the editorial https://link.springer.com/article/10.1007/s00417-019-04518-5

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karhanová, M., Kalitová, J., Kovář, R. et al. Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement. Graefes Arch Clin Exp Ophthalmol 260, 3977–3984 (2022). https://doi.org/10.1007/s00417-022-05760-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-022-05760-0

Keywords

Navigation